GlassScriptPhysician profile
Elizabeth Wegleitner
NPI 1588014757
$6,989.72
in general payments reported to CMS, 2019-2025
10 companies · $74.06 in 2025
The $74.06 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $127 · 2021: $18.73 · 2022: $6,315 · 2023: $394 · 2024: $61.41 · 2025: $74.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $529.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,496.89 | 2022-2023 | Da Vinci Surgical System |
| Organon LLC | $127.97 | 2022-2025 | Nexplanon |
| Gynesonics, INC. | $127.41 | 2020 | |
| Hologic Sales and Service, LLC | $111.80 | 2022-2025 | Myosure Tissue Removal Device, Novasure, Aptima |
| Pfizer INC. | $28.06 | 2023 | |
| Avion Pharmaceuticals | $23.78 | 2022 | |
| Abbvie INC. | $21.83 | 2023 | Lo Loestrin Fe |
| Novo Nordisk INC | $18.73 | 2021 | |
| Lilly USA, LLC | $18.14 | 2025 | Zepbound, Mounjaro |
| Ethicon US, LLC | $15.11 | 2024 | Stratafix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Wegleitner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.